INTERNATIONAL PATENT: HONGLIANG (SHANGHAI) BIOMEDICAL TECHNOLOGY CO., LTD., 弘亮（上海）生物医药科技有限公司 FILES APPLICATION FOR "LIVER-TARGETING COMPOUND, OLIGONUCLEOTIDE CONJUGATE THEREOF, COUPLING METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-04-28

GENEVA, April 28 -- HONGLIANG (SHANGHAI) BIOMEDICAL TECHNOLOGY CO., LTD. (4/F, Unit 3, Building 10, 160 Basheng Road, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 200120), 弘亮（上海）生物医药科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区巴圣路160号10幢3单元4层) filed a patent application (PCT/CN2024/125127) for "LIVER-TARGETING COMPOUND, OLIGONUCLEOTIDE CONJUGATE THEREOF, COUPLING METHOD THEREFOR AND USE THEREOF" on Oct 16, 2024. With pub...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: HONGLIANG (SHANGHAI) BIOMEDICAL TECHNOLOGY CO., LTD., 弘亮（上海）生物医药科技有限公司 FILES APPLICATION FOR "LIVER-TARGETING COMPOUND, OLIGONUCLEOTIDE CONJUGATE THEREOF, COUPLING METHOD THEREFOR AND USE THEREOF"